LifeStance Health (LFST) Receivables - Other (2021 - 2025)
LifeStance Health (LFST) has disclosed Receivables - Other for 5 consecutive years, with $3.8 million as the latest value for Q4 2025.
- On a quarterly basis, Receivables - Other rose 1599.55% to $3.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.8 million, a 1599.55% increase, with the full-year FY2025 number at $3.8 million, up 1599.55% from a year prior.
- Receivables - Other was $3.8 million for Q4 2025 at LifeStance Health, up from $223000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $19.3 million in Q4 2021 to a low of $223000.0 in Q4 2024.
- A 5-year average of $4.7 million and a median of $3.8 million in 2025 define the central range for Receivables - Other.
- Peak YoY movement for Receivables - Other: plummeted 96.68% in 2022, then soared 1599.55% in 2025.
- LifeStance Health's Receivables - Other stood at $19.3 million in 2021, then tumbled by 96.68% to $640000.0 in 2022, then tumbled by 63.28% to $235000.0 in 2023, then decreased by 5.11% to $223000.0 in 2024, then skyrocketed by 1599.55% to $3.8 million in 2025.
- Per Business Quant, the three most recent readings for LFST's Receivables - Other are $3.8 million (Q4 2025), $223000.0 (Q4 2024), and $235000.0 (Q4 2023).